Calcium Channel Blocker Market – Global Industry Analysis and Forecast (2022-2027) by Drug Class, Distribution Channel and Region

Calcium Channel Blocker Market size was valued at US$ 13.66 Bn. in 2021 and the total revenue is expected to grow at 5.62% through 2022 to 2027, reaching nearly US$ 18.96 Bn. in the forecast period.

Calcium Channel Blocker Market Overview:

Calcium channel blockers are the drugs used for treating hypertension and chest pain. These drugs are also known as calcium antagonists. Calcium channel blockers are responsible to lower blood pressure by preventing the calcium from entering the cells of her and arteries. As calcium is responsible to cause more contraction in the heart. And by blocking it allows the blood vessels to relax and open widely. Calcium Channel Blocker Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2027. 2021 is considered a base year however 2021's numbers are on the real output of the companies in the market. Special attention is given to 2021 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done good in lockdown also and specific strategic analysis of those companies is done in the report.

Calcium Channel Blocker Market Dynamics:

The Calcium Channel blocker market is estimated to grow at a high pace due to increasing heart diseases, obesity, unhealthy lifestyle, junk food, overeating are some of the facts leading towards increasing provenance of cardiovascular disease (CVD), blockage in arteries, arrhythmias, and circulatory disorder is leading towards the consumption of calcium channel blocker in the market. In 2017, around 365,914 people were died due to coronary heart disease, being the most common disease nationwide. Due to the rising frequency of cardiovascular disease around the world market players are investing huge amounts to develop innovative therapeutics and to sustain in the market. Also, the amalgamation of drugs to boost the accuracy pharmaceutical market players are focusing on innovating combination of drugs in order lower the consumption of medicine or drugs. For instance, pharmaceutical drugs like Ecosprin AV 75 capsule is a combination of two medicines and used to prevent heart attack, stroke. This capsule is responsible to lower bad cholesterol levels (LDL) like triglycerides and raises the good cholesterol level (HDL) in the body together with a decrease in the formation of blood clots in the body. Hence amalgamation of medicines by the market players is likely to boost the growth of the market. In addition, mergers and acquisitions by the market player to sustain in the market are helping the market to grow. For instance, Pfizer, one of the world’s largest pharmaceutical companies made a strategic acquisition by buying America's giant company Medication for USD 14 billion to ensure it retains its status in the market.

Calcium Channel Blocker Market Segment Analysis:

The Dihydropyridines is dominating the Drug Class segment of the Global Calcium Channel Blocker Market: Dihydropyridines are dominating the calcium channel blocker market. The growth of the market is attributed to expansion in the pharmaceutical industry and increasing research and development activities followed by the market player. Moreover, the rising abundance of hypertensive drugs and medicines related to cardiovascular disease is likely to boost the expansion of the market in the forecast period. moreover, blowout of cardiovascular disease around the globe especially in North America is estimated to fuel the expansion of the market. Dihydropyridines are a popular calcium channel blocker in hypertension treatment. In pharmacology, Dihydropyridines is also known as L- type channel blocker. As the drug has high vascular selectivity as the drug has the capacity to control arterial pressure and vascular resistance, due to which this drug is widely preferred in therapeutics. Some of the Dihydropyridines drugs include amlodipine, nimodipine, felodipine, and nitrendipine. The Retail pharmacy segment is considered to supplement the growth of the Global Calcium Channel Blocker Market. Retail pharmacy is dominating the distribution channel segment in the market. The growth of the segment is attributed to increasing cardiovascular diseases and glowing obesity due to unhealthy lifestyle patterns. As the medication is prescribed on regular basis and Hypertensive medicines are consumed lifelong to maintain the blood pressure. Also, antihypertensive drugs are available on the counter (OTC) platforms. Increasing cardiovascular diseases like hypertension, congenital heart disease, heart attacks, heart failure are boosting the expansion of retail medicine due to high consumption and abundance in the market. Hence this factor is likely to fuel the growth of the market in the forecast period.

Calcium Channel Blocker Market Regional Insights:

Global Calcium Channel Blocker Market Regional Insights is segmented into North America, Asia Pacific, Europe, Latin America, Middle East, and Africa. North America is dominating the Global Calcium Channel Blocker Market Regional Insights with the largest market share of 37.7% in the forecast period. The growth is dominated by the increasing geriatric population and the spread of COVID-19 infection. As the older population is more prone to chronic diseases like Cardiovascular disease, obesity, high blood pressure, low blood pressure. According to World Health Organization (WHO), around 70%-85% of people around the globe have a sedentary lifestyle due to corporate jobs. And this factor has affected mobility in healthy individuals and has given rise to several diseases. As per the Center for Disease Control and prevention around 32 million adults above age 50 are living a sedentary lifestyle and only 1 out of 4 US adults and 1 out of 5 kids are living healthy and mobile life and meeting the standard guideline of physical activity. Hence, this factor is leading toward a high frequency of Cardiovascular Disease (CVD) occurrence and leading towards death that is one person is dying every 40 seconds due to Cardiovascular Disease (CVD). US is leading in terms of CVD and take away the life of around 610,00 people each year. Almost half of the American are at risk and prone to heart disease. The objective of the report is to present a comprehensive analysis of the Global market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global market dynamics, structure by analyzing the market segments and project the Global market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Calcium Channel Blocker Market make the report investor’s guide.

Calcium Channel Blocker Market Scope: Inquire before buying

Global Calcium Channel Blocker Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 13.66 Bn.
Forecast Period 2022 to 2027 CAGR: 5.62% Market Size in 2027: US $ 18.96 Bn.
Segments Covered: by Specimen • Dihydropyridine • Benzothizepine • Phenylalkylamine
by Distribution Channel • Hospital • Retail Pharmacies • Other

Calcium Channel Blocker Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Calcium Channel Blocker Market Key Player

Pfizer • Aventis • Searle • Bayer • AstraZeneca • Knoll Pharmaceuticals • Wyeth-Ayerst • AstraZeneca • Novartis • Sanofi. • ClearSynth • GlaxoSmithKline Plc. • AbMole Bioscience • Lupin Pharmaceuticals, Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Calcium Channel Blocker Market? Ans: North America region held the highest share in 2021. 2. What is the growth rate of Global Calcium Channel Blocker Market? Ans: The Global market is expected to grow at a CAGR of 5.62% during forecast period 2022-2027. 3. What is scope of the Global market report? Ans: Global Calcium Channel Blocker Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Calcium Channel Blocker market? Ans: The important key players in the Global market are – , Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, AstraZeneca, Novartis, Sanofi., ClearSynth, GlaxoSmithKline Plc., AbMole Bioscience, Lupin Pharmaceuticals, and Inc.. 5. What is the study period of this market? Ans: The Global market is studied from 2021 to 2027.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Calcium Channel Blocker Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Calcium Channel Blocker Market 3.4. Geographical Snapshot of the Calcium Channel Blocker Market, By Manufacturer share 4. Global Calcium Channel Blocker Market Overview, 2021-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Calcium Channel Blocker Market 5. Supply Side and Demand Side Indicators 6. Global Calcium Channel Blocker Market Analysis and Forecast, 2021-2027 6.1. Global Calcium Channel Blocker Market Size & Y-o-Y Growth Analysis. 7. Global Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 7.1. Market Size (Value) Estimates & Forecast By Specimen, 2021-2027 7.1.1. Dihydropyridine 7.1.2. Benzothizepine 7.1.3. Phenylalkylamine 7.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 7.2.1. Hospital 7.2.2. Retail Pharmacies 7.2.3. Other 8. Global Calcium Channel Blocker Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 9.1. Market Size (Value) Estimates & Forecast By Specimen, 2021-2027 9.1.1. Dihydropyridine 9.1.2. Benzothizepine 9.1.3. Phenylalkylamine 9.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 9.2.1. Hospital 9.2.2. Retail Pharmacies 9.2.3. Other 10. North America Calcium Channel Blocker Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 11.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 11.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 12. Canada Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 12.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 12.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 13. Mexico Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 13.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 13.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 14. Europe Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 14.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 14.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 15. Europe Calcium Channel Blocker Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 16.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 16.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 17. France Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 17.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 17.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 18. Germany Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 18.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 18.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 19. Italy Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 19.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 19.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 20. Spain Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 20.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 20.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 21. Sweden Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 21.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 21.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 22. CIS Countries Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 22.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 22.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 23. Rest of Europe Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 23.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 23.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 24. Asia Pacific Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 24.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 24.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 25. Asia Pacific Calcium Channel Blocker Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 26.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 26.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 27. India Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 27.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 27.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 28. Japan Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 28.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 28.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 29. South Korea Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 29.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 29.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 30. Australia Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 30.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 30.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 31. ASEAN Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 31.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 31.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 32. Rest of Asia Pacific Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 32.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 32.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 33. Middle East Africa Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 33.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 33.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 34. Middle East Africa Calcium Channel Blocker Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 35.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 35.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 36. GCC Countries Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 36.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 36.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2021-2027 37.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 37.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 38. Nigeria Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 38.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 38.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 39. Rest of ME&A Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 39.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 39.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 40. South America Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 40.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 40.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 41. South America Calcium Channel Blocker Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 42.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 42.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 43. Argentina Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 43.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 43.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 44. Rest of South America Calcium Channel Blocker Market Analysis and Forecasts, 2021-2027 44.1. Market Size (Value) Estimates & Forecast By Drug Class, 2021-2027 44.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Calcium Channel Blocker Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Pfizer 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Pfizer 45.3.3. Aventis 45.3.4. Searle 45.3.5. Bayer 45.3.6. AstraZeneca 45.3.7. Knoll Pharmaceuticals 45.3.8. Wyeth-Ayerst 45.3.9. AstraZeneca 45.3.10. Novartis 45.3.11. Sanofi. 45.3.12. ClearSynth 45.3.13. GlaxoSmithKline Plc. 45.3.14. AbMole Bioscience 45.3.15. Lupin Pharmaceuticals, Inc 46. Primary Key Insights

About This Report

Report ID 117028
Category Healthcare
Published Date Aug 2021
Updated Date April 2022
Contact Us